Stentit

Stentit is a biotech company in Eindhoven. It has raised $15.5M across 3 rounds, most recently an $11.0M Series A in June 2023.

The next generation in stent technology

Headquarters
Eindhoven
Employees
1–10
Business Model
B2B
Total Funding
$15.5M
Last Round
$11.0M Series AJun 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

STENTiT is a Dutch MedTech company transforming vascular reconstruction through its Resorbable Fibrillated Scaffold (RFS), a temporary vascular support structure that triggers a natural healing response to regrow an artery from the inside out. It initially targets below-the-knee chronic limb-threatening ischemia (CLTI), a condition affecting 3.5 million patients in the EU and US, and is led by CEO and founder Bart Sanders.

Summary

It lists 1–10 employees. It has raised $15.5M in total across 3 rounds, most recently a $11.0M Series A round in Jun 2023. Investors include European Innovation Council Fund.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJun 2023
$11.0M

Sign up to see all 3 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Stentit on Indexed.vc
<a href="https://indexed.vc/companies/stentit"><img src="https://indexed.vc/api/badge/company/stentit" alt="Stentit on Indexed.vc" width="260" height="76" /></a>